tiprankstipranks
Trending News
More News >
Assembly Biosciences (ASMB)
NASDAQ:ASMB
US Market

Assembly Biosciences (ASMB) Income Statement

Compare
582 Followers

Assembly Biosciences Income Statement

Last quarter (Q3 2025), Assembly Biosciences's total revenue was $10.79M, an increase of 57.62% from the same quarter last year. In Q3, Assembly Biosciences's net income was $-9.20M. See Assembly Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.52M$ 7.16M$ 0.00$ 6.25M$ 79.11M
Gross Profit
$ 28.52M$ -41.74M$ -69.08M$ 6.25M$ -22.23M
Operating Expenses
$ 73.94M$ 22.91M$ 25.03M$ 138.94M$ 42.54M
Depreciation and Amortization
$ 129.00K$ 450.00K$ 498.00K$ 466.00K$ 691.00K
EBITDA
$ -45.29M$ -64.20M$ -92.52M$ -90.58M$ -58.40M
Operating Income
$ -45.42M$ -64.65M$ -94.11M$ -132.69M$ -64.78M
Other Income/Expenses
$ 5.57M$ 3.45M$ 1.02M$ 302.00K$ 2.62M
Pretax Income
$ -39.85M$ -61.20M$ -93.09M$ -132.39M$ -62.15M
Net Income
$ -40.18M$ -61.23M$ -93.09M$ -129.85M$ -62.15M
Per Share Metrics
Basic EPS
$ -6.69$ -13.38$ -22.82$ -36.00$ -15.00
Diluted EPS
$ -6.69$ -13.38$ -22.82$ -36.00$ -15.00
Weighted Average Shares Outstanding
6.00M 4.58M 4.03M 3.61M-
Weighted Average Shares Outstanding (Diluted)
6.00M 4.58M 4.03M 3.61M-
Currency in USD

Assembly Biosciences Earnings and Revenue History